Macrophages of the Cardiorenal Axis and Myocardial Infarction

Abstract

The aim of our study was to compare the features of macrophage (mf) composition of the kidneys in patients with fatal myocardial infarction (MI) and in patients without cardiovascular diseases (CVD). We used kidney fragments taken during autopsy. Macrophage infiltration was assessed by immunohistochemistry: antibodies CD68 were used as a common mf marker, CD80—M1 type mf marker, CD163, CD206, and stabilin-1—M2 type. Macrophage composition of the kidneys in patients with fatal MI was characterized by the predominance of CD163+ cells among studied cells, and the control group was characterized by the predominance of CD163+, CD206+, and CD68+. In patients with MI, biphasic response from kidney cells was characterized for CD80+ and CD206+: their number decreased by the long-term period of MI; other cells did not show any dynamics. The exact number of CD80+ cells in kidneys of individuals without CVD was slightly higher than in patients with MI, and the number of CD206+—strikingly predominant. Subsequent analysis of CD80+ and CD206+ cells in a larger sample, as well as comparison of data with results obtained from survivors of MI, may bring us closer to understanding whether the influence on these cells can serve as a new target in personalized therapy in postinfarction complications.

Itaconate and citrate releasing polymer attenuates foreign body response in biofabricated cardiac patches

“…7 A). Presence of CD68, a marker for all macrophages, and CD206, commonly a phenotypic marker of M2 polarized macrophages [ [35] , [36] , [37] ], was quantified in both the implant tissue and cardiac tissue regions. In general, greater presence of macrophages was observed in the implant tissue area compared to the underlying myocardial tissue space.…”

Cardiovascular and Metabolic Disease: New Treatments and Future Directions 2.0

“…Projections indicate a steady rise in prevalence, with estimates indicating a rise to 10.2% (578 million) by 2030 and 10.9% (700 million) by 2045 [6]. Alarmingly, 1.5 million deaths are directly attributed to diabetes annually, accentuating the imperative for the early detection and comprehensive management of these interrelated conditions [7].…”